|
WO2021034996A2
|
|
Treatment of cardiovascular diseases
|
|
WO2020231968A1
|
|
High concentration cell packaging and shipping
|
|
CN103748210A
|
|
Stem cells packaging and shipping
|
|
CA2762853A1
|
|
Cell therapy for brain tissue damage
|
|
CN102438631A
|
|
Hiv-resistant stem cells and uses thereof
|
|
WO2009120368A2
|
|
Treatment of brain damage using umbilical cord blood cells
|
|
US2008008693A1
|
|
Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions
|
|
AU2006252363A1
|
|
Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
|
|
CN101252834A
|
|
Plasma-depleted, non-red blood cell-depleted umbilical cord blood compositions and methods of use
|
|
US2003215942A1
|
|
Undesignated allogeneic stem cell bank
|
|
WO03045335A2
|
|
Stem cell screening and transplantation therapy for hiv infection
|
|
US6670124B1
|
|
High throughput methods of HLA typing
|
